Health Care: Drugs

Hyperion Therapeutics Inc (HPTX: NASDAQ)

$45.95 -0.02 | -0.04%
04/27/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 45.97
52 Week High 46.96
52 Week Low 20.23
Avg. Daily Vol. (Mil) 0.53
Beta (3 year) -0.14
Share Related Items
Mkt Cap (Mil) 955.01
Shares Out (Mil) 20.77
Float (Mil) 9.71
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.00
Current Ratio 5.20
LT Debt/ Equity 0.14
Total Debt / Equity 0.14
Valuation Ratios
Price Earnings n.a.
Price/Sales 8.41
Price/Book 7.26
Price/Cash Flow -8.76K
Per Share Data
Earnings -0.31
Sales 5.47
Book Value 6.33
Cash Flow -0.01
Business Summary
Hyperion Therapeutics Inc is a commercial biopharmaceutical company engaged in the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology.
General Information
2000 Sierra Point Parkway
Suite 400
Brisbane, CA 94005
Industry : Drugs
Sector: Health Care
Employees: 80
CEO: Donald J. Santel
Short Interest
Current Month (Mil) 0.39
Previous Month (Mil) 0.85
Short Interest Ratio (Days) 0.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -3.50
Return on Investments -4.20
Gross Margin 89.30
EBIT Margin -3.80
Profit Margin -5.50

Portfolios with HPTX

Latest HPTX Headlines from TheStreet

More Financial News for HPTX

Press Releases for HPTX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter